Synthetic Biologics (AMEX:SYN) reported quarterly losses of $(0.02) per share which met the analyst consensus estimate. This is a 85.71 percent increase over losses of $(0.14) per share from the same period last year.
Synthetic Biologics (AMEX:SYN) reported quarterly losses of $(0.02) per share which met the analyst consensus estimate. This is a 85.71 percent increase over losses of $(0.14) per share from the same period last year.
精彩评论